Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.
about
Aspirin as adjunctive treatment for giant cell arteritisA candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCAAssociation Between Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) Polymorphisms and Risk of Ankylosing Spondylitis: A Meta-analysis.Association of PTPN22 polymorphsims and ankylosing spondylitis susceptibility.PTPN22: the archetypal non-HLA autoimmunity gene.A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis).PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis.A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.Giant cell arteritis and polymyalgia rheumatica: an update.Revisited HLA and non-HLA genetics of Takayasu arteritis--where are we?New insights into the pathogenesis of giant cell arteritis and hopes for the clinic.Genetic variants in ANCA-associated vasculitis: a meta-analysis.Polymorphisms in Protein Tyrosine Phosphatase Non-receptor Type 2 and 22 (PTPN2/22) Are Linked to Hyper-Proliferative T-Cells and Susceptibility to Mycobacteria in Rheumatoid Arthritis.Role of PTPN2/22 polymorphisms in pathophysiology of Crohn's disease.A variant within intron 1 of the PTPN22 gene decreases the genetic susceptibility of ankylosing spondylitis in a central south Chinese Han population.Influence of theIL17A locusin giant cell arteritis susceptibility
P2860
Q24194497-97B3CE28-216E-47FF-81C3-A5857F463CF9Q28545058-2D1EAEE9-EB14-4D7B-88FE-2968444680C2Q33772162-FE5A32EB-AA4F-4628-8603-37D776BA84CAQ35145104-2BDD5757-D49A-4C81-93CE-203CF255550FQ35221741-E1ED0F20-5A5F-4781-87E7-D8F851B48DF4Q35266391-B1EC8FF4-F9CA-4184-BE64-F05B3663784CQ36155846-95B345F8-685C-4E07-978C-677605F88E19Q36819307-A38F0979-0AC4-4344-A331-C83B7261E779Q37575470-0AE0E857-C0DC-4681-A163-4B9AECF608D5Q38331238-4A49EB57-BC65-4905-8A10-0474EF9D0812Q38547821-9985796D-AFF5-48A4-B000-02EFCCD9D770Q38586408-42E98DEF-5FB0-4E68-9F4A-F48F2F6AC6DBQ40459136-CA65458E-8A04-4185-816A-AE7090DDE799Q49588830-F9481EB0-7EEE-4CA8-80B0-E1014B5DA0C4Q49885480-A45A960A-D2EF-434A-8175-5C68A789567EQ54212309-C7CC6104-5AA5-4C37-A040-7C351B821029Q57307049-F0B94FB7-55CD-4C1D-96DE-064A6C3592DA
P2860
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of the PTPN22 f ...... ctor for giant cell arteritis.
@ast
Identification of the PTPN22 f ...... ctor for giant cell arteritis.
@en
type
label
Identification of the PTPN22 f ...... ctor for giant cell arteritis.
@ast
Identification of the PTPN22 f ...... ctor for giant cell arteritis.
@en
prefLabel
Identification of the PTPN22 f ...... ctor for giant cell arteritis.
@ast
Identification of the PTPN22 f ...... ctor for giant cell arteritis.
@en
P2093
P2860
P50
P1476
Identification of the PTPN22 f ...... actor for giant cell arteritis
@en
P2093
A Unzurrunzaga
A W Morgan
B Marí-Alfonso
E de Miguel
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-203641
P407
P50
P577
2013-08-14T00:00:00Z